ATE449600T1 - Verwendung von glycerin zur verbesserung der herzfunktion - Google Patents

Verwendung von glycerin zur verbesserung der herzfunktion

Info

Publication number
ATE449600T1
ATE449600T1 AT06763271T AT06763271T ATE449600T1 AT E449600 T1 ATE449600 T1 AT E449600T1 AT 06763271 T AT06763271 T AT 06763271T AT 06763271 T AT06763271 T AT 06763271T AT E449600 T1 ATE449600 T1 AT E449600T1
Authority
AT
Austria
Prior art keywords
glycerin
heart function
improve heart
cardiac
improve
Prior art date
Application number
AT06763271T
Other languages
English (en)
Inventor
Alain Grynberg
Segolene Gambert
Cecile Helies-Toussaint
Original Assignee
Agronomique Inst Nat Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech filed Critical Agronomique Inst Nat Rech
Application granted granted Critical
Publication of ATE449600T1 publication Critical patent/ATE449600T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT06763271T 2005-05-25 2006-05-24 Verwendung von glycerin zur verbesserung der herzfunktion ATE449600T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05291124A EP1731145A1 (de) 2005-05-25 2005-05-25 Verwendung von Glycerol zur Verbesserung der Herzfunktion
PCT/EP2006/062584 WO2006125799A1 (en) 2005-05-25 2006-05-24 Use of glycerol for improving cardiac function

Publications (1)

Publication Number Publication Date
ATE449600T1 true ATE449600T1 (de) 2009-12-15

Family

ID=34942345

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06763271T ATE449600T1 (de) 2005-05-25 2006-05-24 Verwendung von glycerin zur verbesserung der herzfunktion

Country Status (6)

Country Link
US (1) US20080275136A1 (de)
EP (2) EP1731145A1 (de)
AT (1) ATE449600T1 (de)
CA (1) CA2609158A1 (de)
DE (1) DE602006010691D1 (de)
WO (1) WO2006125799A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2156188B1 (de) 2007-03-28 2021-05-05 University of Southern California Induktion differentieller stressresistenz und verwendungen davon
EP2211872A4 (de) * 2007-11-02 2012-01-04 Univ British Columbia Hyperverzweigtes polyglycerol zur verbesserung der herzfunktion
JP2011523626A (ja) * 2008-04-24 2011-08-18 ユニバーシティー オブ サウザン カリフォルニア，ユーエスシー スティーブンズ 化学療法、放射線療法、酸化ストレス、および加齢を防御するための食事組成物ならびに方法
EP3505167A1 (de) * 2012-10-25 2019-07-03 Run Them Sweet LLC Unterstützung des nährstoffbedarfs menschlicher und anderer patienten
US10206422B2 (en) 2012-10-25 2019-02-19 Run Them Sweet Llc Systems and methods for monitoring of blood lactate and targeting of blood lactate via nutritional support
US9687011B2 (en) 2012-10-25 2017-06-27 Run Them Sweet Llc Blood lactate range targets and nutritional formulations and protocols to support patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147650A (en) * 1988-07-29 1992-09-15 University Of Florida Compositions and methods for achieving improved physiological response to exercise
US7081465B2 (en) * 2003-03-31 2006-07-25 Council Of Scientific And Industrial Research Alpha-substituted naphthyloxy omega-substituted alky/aryl amino-substituted alkane derivatives as agent for treatment or prophylaxis of diabetes and related metabolic disorders

Also Published As

Publication number Publication date
EP1731145A1 (de) 2006-12-13
US20080275136A1 (en) 2008-11-06
EP1885346B1 (de) 2009-11-25
WO2006125799A1 (en) 2006-11-30
DE602006010691D1 (de) 2010-01-07
EP1885346A1 (de) 2008-02-13
CA2609158A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
ATE538665T1 (de) Lipidzusammensetzung zur verbesserung der hirnfunktion
EA201100765A1 (ru) Наночастицы длительной циркуляции для замедленного высвобождения терапевтических средств
EA200870019A1 (ru) Лактамовые соединения и способы их применения
AR033510A1 (es) Inhibidores de la oxidacion parcial de acidos grasos para el tratamiento de la insuficiencia cardiaca congestiva
MY166613A (en) Glycerol levulinate ketals and their use
EA200970519A1 (ru) Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения
EA201071320A1 (ru) Активаторы глюкокиназы
MX359949B (es) Anticuerpos para troponina i y metodos de uso de los mismos.
WO2010120368A3 (en) Stabilization of radiopharmaceutical compositions using ascorbic acid
CL2009000782A1 (es) Metodo que comprende un compuesto derivado de oximetilen-arilo sustituido, inhibidores de dpp-iv; y su uso en el tratamiento de la diabetes y disminucion de trigliceridos, entre otras enfermedades.
WO2005086860A3 (en) Methods for generating insulin-producing cells
PE20081372A1 (es) COMPOSICION FARMACEUTICA QUE COMPRENDE 2-[4-(7-ETIL-5H-PIRROLO[2,3-b]PIRAZIN-6-IL)-FENIL]-PROPAN-2-OL COMO INHIBIDOR DE QUINASA
CY1112590T1 (el) 3-[4-(ΔΙΒΕΝΖΟ[b,f][1,4]ΟΞΑΖΕΠΙΝ-11-ΥΛΟ)-ΠΙΠΕΡΑΖΙΝ-1-ΥΛΟ]-2,2-ΔΙΜΕΘΥΛΟ ΠΡΟΠΑΝΟΪΚΟ ΟΞΥ ΓΙΑ ΧΡΗΣΗ ΣΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΔΙΑΤΑΡΑΧΩΝ ΤΟΥ ΥΠΝΟΥ
UA110696C2 (uk) 7-[3,5-дигідрокси-2-(3-гідрокси-5-фенілпент-1-еніл)циклопентил]-n-етилгепт-5-енамід (біматопрост) у кристалічній формі ii, спосіб його одержання й спосіб його застосування
EP2498797A4 (de) Behandlung von herzkrankheiten
EA200702614A1 (ru) Способы получения 4-(бифенилил)азетидин-2-оналкилфосфиновых кислот
WO2010011331A3 (en) Compositions and methods related to sirt1 function
EA200701390A1 (ru) Способ получения легкодоступного клеточного материала из пуповинной крови и композиция на его основе
ATE473288T1 (de) Enzymatische decarboxylierung von 2-keto-l- gulonsäure zur herstellung von xylose
AR048938A1 (es) Cepas de levadura que producen colesterol y sus aplicaciones
ATE449600T1 (de) Verwendung von glycerin zur verbesserung der herzfunktion
MX2015009054A (es) Composicion cosmetica o dermatologica que comprende una merocianina, una fase aceitosa y un monoalcanol c1-c4.
EA201001405A1 (ru) Стимуляторы секреции инсулина - производные пиридопиразинонов, способы их получения и их применение для лечения диабета
MY151228A (en) Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
ATE530660T1 (de) Enzymatische herstellung von (meth)acrylsäureestern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties